17-76074890-G-C

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_003857.4(GALR2):​c.7G>C​(p.Val3Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000728 in 1,373,214 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V3I) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 7.3e-7 ( 0 hom. )

Consequence

GALR2
NM_003857.4 missense

Scores

1
17

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0340

Publications

0 publications found
Variant links:
Genes affected
GALR2 (HGNC:4133): (galanin receptor 2) Galanin is an important neuromodulator present in the brain, gastrointestinal system, and hypothalamopituitary axis. It is a 30-amino acid non-C-terminally amidated peptide that potently stimulates growth hormone secretion, inhibits cardiac vagal slowing of heart rate, abolishes sinus arrhythmia, and inhibits postprandial gastrointestinal motility. The actions of galanin are mediated through interaction with specific membrane receptors that are members of the 7-transmembrane family of G protein-coupled receptors. GALR2 interacts with the N-terminal residues of the galanin peptide. The primary signaling mechanism for GALR2 is through the phospholipase C/protein kinase C pathway (via Gq), in contrast to GALR1, which communicates its intracellular signal by inhibition of adenylyl cyclase through Gi. However, it has been demonstrated that GALR2 couples efficiently to both the Gq and Gi proteins to simultaneously activate 2 independent signal transduction pathways. [provided by RefSeq, Jul 2008]
ZACN (HGNC:29504): (zinc activated ion channel) LGICZ1 is a zinc-activated ligand-gated ion channel that defines a new subgroup of the cysteine-loop superfamily of ligand-gated ion channels (Davies et al., 2003 [PubMed 12381728]).[supplied by OMIM, Mar 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.043177366).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003857.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GALR2
NM_003857.4
MANE Select
c.7G>Cp.Val3Leu
missense
Exon 1 of 2NP_003848.1O43603

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GALR2
ENST00000329003.4
TSL:1 MANE Select
c.7G>Cp.Val3Leu
missense
Exon 1 of 2ENSP00000329684.3O43603
ZACN
ENST00000591500.1
TSL:4
n.216+2714G>C
intron
N/A

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
7.28e-7
AC:
1
AN:
1373214
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
676598
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31370
American (AMR)
AF:
0.00
AC:
0
AN:
35280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24192
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35646
South Asian (SAS)
AF:
0.00
AC:
0
AN:
76944
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
33870
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4022
European-Non Finnish (NFE)
AF:
9.31e-7
AC:
1
AN:
1074566
Other (OTH)
AF:
0.00
AC:
0
AN:
57324
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
8.8
DANN
Benign
0.78
DEOGEN2
Benign
0.048
T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.20
N
LIST_S2
Benign
0.39
T
M_CAP
Benign
0.025
D
MetaRNN
Benign
0.043
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.34
N
PhyloP100
0.034
PrimateAI
Uncertain
0.65
T
PROVEAN
Benign
-0.070
N
REVEL
Benign
0.043
Sift
Benign
0.70
T
Sift4G
Benign
0.19
T
Polyphen
0.049
B
Vest4
0.069
MutPred
0.13
Loss of catalytic residue at V3 (P = 0.1397)
MVP
0.52
ClinPred
0.033
T
GERP RS
2.0
PromoterAI
0.011
Neutral
Varity_R
0.053
gMVP
0.30

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199821083; hg19: chr17-74070971; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.